Emerson J D, Burdick E, Hoaglin D C, Mosteller F, Chalmers T C
Department of Health Policy and Management, Harvard School of Public Health, Boston, Massachusetts 02115.
Control Clin Trials. 1990 Oct;11(5):339-52. doi: 10.1016/0197-2456(90)90175-2.
Meta-analytic investigations sometimes use assessments of research quality according to a formal protocol as a tool for improving research synthesis. We asked whether a particular quality scoring system could have a direct use in adjusting the summary estimates of a treatment difference. In an empirical study of the relation of quality scores to treatment differences in published meta-analyses of 7 groups of controlled randomized clinical trials comprising 107 primary studies, we found no relation between treatment difference and overall quality score. We also found no relation between quality score and variation in treatment difference. The level of quality scores has increased at a rate of 9% per decade for three decades, averaging 0.51 on a scale of 0 to 1 for the 1980s, and leaving much room for improvement. Nevertheless, attention to quality of studies by editors, reviewers, and authors may be raising both the level of research done and quality of the reports.
元分析研究有时会根据正式方案对研究质量进行评估,并将其作为改进研究综合分析的一种工具。我们探讨了一种特定的质量评分系统是否可直接用于调整治疗差异的汇总估计值。在一项实证研究中,我们分析了7组包含107项主要研究的对照随机临床试验的已发表元分析中质量评分与治疗差异之间的关系,结果发现治疗差异与总体质量评分之间没有关联。我们还发现质量评分与治疗差异的变异性之间也没有关系。在过去三十年中,质量评分水平以每十年9%的速度上升,在20世纪80年代,0至1的评分尺度上平均为0.51,仍有很大的改进空间。尽管如此,编辑、审稿人和作者对研究质量的关注可能正在提高研究水平和报告质量。